Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Community Oncologists: The Show and After Show
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: January 6th 2023 | Updated: April 23rd 2025
Bridging Options for CAR T-Cell Therapy in R/R DLBCL
Published: April 17th 2025 | Updated: April 23rd 2025
Dara-VRd Leads to Sustained MRD Negativity in Newly Diagnosed Myeloma
Published: April 15th 2025 | Updated: April 23rd 2025
Participants Explain Rationale for Different IO/TKI Options for ccRCC
Published: April 20th 2025 | Updated: April 23rd 2025
The Targeted Pulse: FDA Approvals in HCC and CRC, Promise for SCLC, and More